Efficacy and Safety of Phosphoinositide 3-Kinase (PI3K) Inhibitors in Non-Hodgkin's Lymphoma: A Systematic Review and Meta-Analysis

被引:1
|
作者
Khan, Sana Irfan
Anwar, Muhammad Yasir
Rafae, Abdul
Khan, Anam
Khan, Atif Irfan
Aamir, Sobia
Batool, Syeda Sabeeka
Din, Asim Tameez Ud
Khan, Israr
Javaid, Anum
Qadeer, Haifza Abeera
Ahmed, Zahoor
Gul, Rohail
Aijaz, Zobia
Anwer, Faiz
机构
关键词
D O I
10.1182/blood-2020-134986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] A bibliometric analysis of highly cited Phosphoinositide 3-Kinase (PI3K) research papers
    Ho, Yuh-Shan
    Hartley, James
    COLLNET JOURNAL OF SCIENTOMETRICS AND INFORMATION MANAGEMENT, 2020, 14 (01) : 37 - 54
  • [22] PI3K-selective and PI3K/-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma
    Lampson, Benjamin L.
    Brown, Jennifer R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1267 - 1279
  • [23] Allergic conditions are not associated with the risk of non-Hodgkin's lymphoma or Hodgkin's lymphoma: a systematic review and meta-analysis
    Yang, Jia
    Xu, Hong'en
    Liang, Xiaodong
    Lv, Shiliang
    Lin, Baihua
    Jia, Yongshi
    ONCOTARGETS AND THERAPY, 2017, 10 : 2189 - 2198
  • [24] THE INCIDENCE OF NON-HODGKIN LYMPHOMA IN IRAN: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Fouladseresht, H.
    Ghorbani, M.
    Hassanipour, S.
    Delam, H.
    Mokhtari, Am.
    Mohseni, S.
    Abdzadeh, E.
    Riahi, S.
    Mohammadian-Hafshejani, A.
    Salehiniya, H.
    WORLD CANCER RESEARCH JOURNAL, 2019, 6
  • [25] Roles of PI3K pan-inhibitors and PI3K-δ inhibitors in allergic lung inflammation: a systematic review and meta-analysis
    Jong Seung Kim
    Jae Seok Jeong
    Sam Hyun Kwon
    So Ri Kim
    Yong Chul Lee
    Scientific Reports, 10
  • [26] Roles of PI3K pan-inhibitors and PI3K-δ inhibitors in allergic lung inflammation: a systematic review and meta-analysis
    Kim, Jong Seung
    Jeong, Jae Seok
    Kwon, Sam Hyun
    Kim, So Ri
    Lee, Yong Chul
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors
    Wu, Peng
    Su, Yi
    Liu, Xiaowen
    Yang, Bo
    He, Qiaojun
    Hu, Yongzhou
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (09) : 2837 - 2844
  • [28] Comparative Efficacy, Safety, and CostEffectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
    Albakri, Khaled
    Khater, Bashar
    Aldemerdash, Mohamed A.
    Shahin, Hatim Nasruldin
    Aldemerdash, Ahmed
    Saleh, Othman
    Alsafuti, Mohammad Nabeel
    Alnajjar, Roa'a
    Khaity, Abdulrhman
    Ammari, Omar
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S501 - S502
  • [29] Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Matsunaga, Shinji
    Fujishiro, Hiroshige
    Takechi, Hajime
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (04) : 1031 - 1039
  • [30] Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin's Lymphoma: A Systematic Review and Meta-analysis
    Lee, Soohyun
    Lee, Heeyoung
    Kim, EunYoung
    BIODRUGS, 2019, 33 (05) : 469 - 483